Educational activities

2023 meetings

The following EHA-SWG meetings took place in the past calendar year:

  • 54th General Assembly of ERIC members at ELN Symposium 2023
    Mannheim, Germany
    April 18, 2023
  • ERIC/Brazilian CLL Group workshop on biomarkers in CLL
    Brasilia, Brazil
    May 25–26, 2023
  • 55th General Assembly of ERIC members at EHA2023
    Frankfurt, Germany
    June 8, 2023
  • ERIC International Preceptorship, Stresa 2023
    Stresa, Italy
    November 17–18, 2023
  • 56th General Assembly of ERIC members at ASH
    San Diego, USA
    December 10, 2023

2023 projects

  • Clonal Relationship in Richter Transformation (RT).
  • Crowdsourcing Initiative.
  • RESOLVE Trial: an international, multi-center, randomized, controlled pragmatic clinical trial.
  • Evolution of survival and management of patients with CLL in the general population over two periods: 2011-2012 compared to 2017-2018.
  • Treatment sequencing patterns and outcomes in patients with chronic lymphocytic leukemia treated with BTK inhibitors.
  • Dissecting the novel treatment landscape for CLL in Europe and identifying a new “high-risk” category in patients with M-CLL: an ERIC real world evidence study.
  • Contextualizing survival differences of patients with CLL over two periods: CIT-era compared to BTKi era.
  • Cardiovascular assessment on initiation and subsequent monitoring during BTKi therapy.
  • PEDRO – Peer 2 Peer Support for Adverse Drug Reaction Management in CLL Patients.
Share